BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 22848660)

  • 1. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
    Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
    PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
    Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
    Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma.
    Zheng FF; Zhu LM; Nie AF; Li XY; Lin JR; Zhang K; Chen J; Zhou WL; Shen ZJ; Zhu YC; Wang JG; Zhu DL; Gao PJ
    Hypertension; 2015 Mar; 65(3):622-8. PubMed ID: 25624344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas.
    Yamada M; Nakajima Y; Taguchi R; Okamura T; Ishii S; Tomaru T; Ozawa A; Shibusawa N; Yoshino S; Toki A; Ishida E; Hashimoto K; Satoh T; Mori M
    Endocr J; 2012; 59(8):735-41. PubMed ID: 22863749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of Aldosterone-Producing Adenoma in Korean Patients.
    Hong AR; Kim JH; Song YS; Lee KE; Seo SH; Seong MW; Shin CS; Kim SW; Kim SY
    PLoS One; 2016; 11(1):e0147590. PubMed ID: 26807823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
    Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
    Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
    Nanba K; Omata K; Else T; Beck PCC; Nanba AT; Turcu AF; Miller BS; Giordano TJ; Tomlins SA; Rainey WE
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3869-3876. PubMed ID: 30085035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients.
    Nanba K; Yamazaki Y; Bick N; Onodera K; Tezuka Y; Omata K; Ono Y; Blinder AR; Tomlins SA; Rainey WE; Satoh F; Sasano H
    J Clin Endocrinol Metab; 2020 Nov; 105(11):e4066-73. PubMed ID: 32844168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.
    Nanba K; Omata K; Gomez-Sanchez CE; Stratakis CA; Demidowich AP; Suzuki M; Thompson LDR; Cohen DL; Luther JM; Gellert L; Vaidya A; Barletta JA; Else T; Giordano TJ; Tomlins SA; Rainey WE
    Hypertension; 2019 Apr; 73(4):885-892. PubMed ID: 30739536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
    Choi M; Scholl UI; Yue P; Björklund P; Zhao B; Nelson-Williams C; Ji W; Cho Y; Patel A; Men CJ; Lolis E; Wisgerhof MV; Geller DS; Mane S; Hellman P; Westin G; Åkerström G; Wang W; Carling T; Lifton RP
    Science; 2011 Feb; 331(6018):768-72. PubMed ID: 21311022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
    Fernandes-Rosa FL; Giscos-Douriez I; Amar L; Gomez-Sanchez CE; Meatchi T; Boulkroun S; Zennaro MC
    Hypertension; 2015 Nov; 66(5):1014-22. PubMed ID: 26351028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
    Okamura T; Nakajima Y; Katano-Toki A; Horiguchi K; Matsumoto S; Yoshino S; Yamada E; Tomaru T; Ishii S; Saito T; Ozawa A; Shibusawa N; Satoh T; Okada S; Nagaoka R; Takada D; Horiguchi J; Oyama T; Yamada M
    Endocr J; 2017 Jan; 64(1):39-47. PubMed ID: 27681703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.
    Scholl UI; Goh G; Stölting G; de Oliveira RC; Choi M; Overton JD; Fonseca AL; Korah R; Starker LF; Kunstman JW; Prasad ML; Hartung EA; Mauras N; Benson MR; Brady T; Shapiro JR; Loring E; Nelson-Williams C; Libutti SK; Mane S; Hellman P; Westin G; Åkerström G; Björklund P; Carling T; Fahlke C; Hidalgo P; Lifton RP
    Nat Genet; 2013 Sep; 45(9):1050-4. PubMed ID: 23913001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.
    Scholl UI; Nelson-Williams C; Yue P; Grekin R; Wyatt RJ; Dillon MJ; Couch R; Hammer LK; Harley FL; Farhi A; Wang WH; Lifton RP
    Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2533-8. PubMed ID: 22308486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
    Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
    Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC
    Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.